A detailed history of Candriam S.C.A. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 328,978 shares of TMO stock, worth $175 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
328,978
Previous 431,658 23.79%
Holding current value
$175 Million
Previous $239 Million 14.76%
% of portfolio
1.19%
Previous 1.47%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$531.86 - $624.21 $54.6 Million - $64.1 Million
-102,680 Reduced 23.79%
328,978 $203 Million
Q2 2024

Aug 05, 2024

BUY
$541.52 - $599.02 $2.48 Million - $2.74 Million
4,571 Added 1.07%
431,658 $239 Million
Q1 2024

May 03, 2024

SELL
$528.82 - $599.43 $36.1 Million - $40.9 Million
-68,180 Reduced 13.77%
427,087 $248 Million
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $16.3 Million - $20.2 Million
37,855 Added 8.28%
495,267 $263 Million
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $4.28 Million - $4.94 Million
-8,595 Reduced 1.84%
457,412 $232 Million
Q2 2023

Aug 08, 2023

BUY
$508.46 - $591.13 $6.76 Million - $7.86 Million
13,304 Added 2.94%
466,007 $243 Million
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $7.23 Million - $8.17 Million
13,509 Added 3.08%
452,703 $261 Million
Q4 2022

Feb 13, 2023

BUY
$484.71 - $571.37 $5.49 Million - $6.47 Million
11,330 Added 2.65%
439,194 $242 Million
Q3 2022

Nov 10, 2022

BUY
$507.19 - $604.49 $12 Million - $14.3 Million
23,598 Added 5.84%
427,864 $217 Million
Q2 2022

Aug 03, 2022

BUY
$500.9 - $612.21 $10.1 Million - $12.4 Million
20,224 Added 5.27%
404,266 $220 Million
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $19.3 Million - $23.7 Million
-36,750 Reduced 8.73%
384,042 $227 Million
Q4 2021

Feb 10, 2022

BUY
$569.0 - $667.24 $31.3 Million - $36.7 Million
54,977 Added 15.03%
420,792 $281 Million
Q3 2021

Nov 09, 2021

BUY
$509.53 - $609.78 $6.47 Million - $7.74 Million
12,692 Added 3.59%
365,815 $209 Million
Q2 2021

Jul 20, 2021

SELL
$441.0 - $508.24 $5.6 Million - $6.46 Million
-12,703 Reduced 3.47%
353,123 $178 Million
Q1 2021

Apr 29, 2021

SELL
$439.85 - $518.83 $2,639 - $3,112
-6 Reduced -0.0%
365,826 $164 Million
Q4 2020

Jan 22, 2021

BUY
$435.06 - $527.66 $7.22 Million - $8.76 Million
16,594 Added 4.75%
365,832 $170 Million
Q3 2020

Oct 19, 2020

BUY
$359.77 - $441.52 $29.8 Million - $36.6 Million
82,897 Added 31.12%
349,238 $154 Million
Q2 2020

Jul 23, 2020

BUY
$275.2 - $362.34 $31 Million - $40.8 Million
112,713 Added 73.37%
266,341 $96.5 Million
Q1 2020

May 26, 2020

BUY
$255.3 - $340.05 $7,403 - $9,861
29 Added 0.02%
153,628 $48.8 Million
Q4 2019

Jan 21, 2020

BUY
$271.93 - $328.04 $13.5 Million - $16.2 Million
49,530 Added 47.59%
153,599 $50,000
Q3 2019

Oct 21, 2019

BUY
$268.46 - $305.43 $2.84 Million - $3.23 Million
10,569 Added 11.3%
104,069 $30,000
Q2 2019

Aug 01, 2019

BUY
$257.51 - $295.55 $5.26 Million - $6.04 Million
20,429 Added 27.96%
93,500 $27.3 Million
Q1 2019

May 02, 2019

SELL
$212.17 - $273.72 $3.04 Million - $3.92 Million
-14,335 Reduced 16.4%
73,071 $20 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $1.62 Million - $1.96 Million
7,788 Added 9.78%
87,406 $19.6 Million
Q3 2018

Nov 07, 2018

BUY
$205.57 - $244.32 $4.62 Million - $5.49 Million
22,488 Added 39.36%
79,618 $19.4 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $1.87 Million - $2.02 Million
9,202 Added 19.2%
57,130 $11.8 Million
Q1 2018

May 09, 2018

BUY
$192.98 - $224.11 $134,700 - $156,428
698 Added 1.48%
47,928 $9.9 Million
Q4 2017

Feb 07, 2018

BUY
$182.03 - $200.37 $73,904 - $81,350
406 Added 0.87%
47,230 $8.97 Million
Q3 2017

Nov 03, 2017

BUY
$171.74 - $194.04 $8.04 Million - $9.09 Million
46,824
46,824 $8.86 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $209B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.